D-0827-2016 Class II Terminated
FDA drug recall D-0827-2016 was initiated by Hospira Inc. on Mar 8, 2016 and is designated Class II. Reason for recall: Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin. The recall status is terminated (terminated Dec 6, 2017). Affected quantity: 11256 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 27, 2016
- Initiation Date
- Mar 8, 2016
- Termination Date
- Dec 6, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11256 bags
Product description
Dextrose Injection, USP, 70%, Packaged as 500 mL in 1000 mL Bag, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7918-19, Barcode (01) 0 030409 791819 5
Reason for recall
Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.
Distribution pattern
US: Nationwide and Singapore
Code information
Lot# 48-010-JT, Exp 12/16
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0827-2016
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Hospira Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.